Trust Co. of Vermont boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.2% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 35,725 shares of the healthcare conglomerate’s stock after acquiring an additional 1,779 shares during the period. UnitedHealth Group comprises about 1.0% of Trust Co. of Vermont’s holdings, making the stock its 25th biggest holding. Trust Co. of Vermont’s holdings in UnitedHealth Group were worth $20,888,000 as of its most recent filing with the SEC.
A number of other large investors also recently added to or reduced their stakes in the stock. Harbor Investment Advisory LLC raised its position in shares of UnitedHealth Group by 3.2% in the first quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock valued at $17,783,000 after buying an additional 1,129 shares during the last quarter. Austin Private Wealth LLC raised its position in shares of UnitedHealth Group by 9.8% in the first quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock valued at $573,000 after buying an additional 111 shares during the last quarter. Capital Insight Partners LLC raised its position in shares of UnitedHealth Group by 3.8% in the first quarter. Capital Insight Partners LLC now owns 9,045 shares of the healthcare conglomerate’s stock valued at $4,475,000 after buying an additional 332 shares during the last quarter. Global Assets Advisory LLC acquired a new stake in shares of UnitedHealth Group in the first quarter valued at about $282,469,000. Finally, Tealwood Asset Management Inc. acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $2,905,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of brokerages recently issued reports on UNH. Morgan Stanley dropped their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday. Bank of America dropped their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday. Argus upped their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Truist Financial reissued a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday. Two analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $615.16.
UnitedHealth Group Stock Down 0.9 %
Shares of NYSE:UNH opened at $566.00 on Friday. The firm’s 50 day moving average price is $584.20 and its 200 day moving average price is $533.07. The stock has a market cap of $522.66 billion, a price-to-earnings ratio of 37.53, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $608.63. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same quarter last year, the company earned $6.56 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.68 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a dividend of $2.10 per share. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio is presently 55.70%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Investing in the High PE Growth Stocks
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- 3 Warren Buffett Stocks to Buy Now
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.